A new class of 2-oxo-tetrahydro-1,8-naphthyridine-based protein farnesyltransferase inhibitors were synthesized and found to inhibit protein farnesyltransferase from the malaria parasite with potencies in the low nanomolar range. The compounds were much less potent on mammalian protein prenyltransferases. Two of the compounds block the growth of malaria in culture with potencies in the sub-micromolar range. Some of the compounds were found to be much more metabolically stable than previously described tetrahydroquinoline-based protein farnesyltransferase inhibitors. (c) 2007 Elsevier Ltd. All rights reserved
Third world nations require immediate access to inexpensive therapeutics to counter the high mortali...
A series of protein farnesyltransferase inhibitor ester prodrugs of FTI-2148 (17) were synthesized i...
Third world nations require immediate access to inexpensive therapeutics to counter the high mortali...
A new class of 2-oxo-tetrahydro-1,8-naphthyridine-based protein farnesyltransferase inhibitors were ...
Substituted tetrahydroquinolines (THQs) have been previously identified as inhibitors of mammalian p...
Substituted tetrahydroquinolines (THQs) have been previously identified as inhibitors of mammalian p...
Substituted tetrahydroquinolines (THQs) have been previously identified as inhibitors of mammalian p...
Malaria continues to represent a very serious health problem in the tropics. The current methods of ...
New chemotherapeutics are urgently needed to combat malaria. We previously reported on a novel serie...
New chemotherapeutics are urgently needed to combat malaria. We previously reported on a novel serie...
New therapeutics to combat malaria are desperately needed. Here we show that the enzyme protein farn...
New chemotherapeutics are urgently needed to combat malaria. We previously reported on a novel serie...
New therapeutics to combat malaria are desperately needed. Here we show that the enzyme protein farn...
A series of ester derivatives of 17 with increased lipophilicity were synthesized and tested against...
A series of protein farnesyltransferase inhibitor ester prodrugs of FTI-2148 (17) were synthesized i...
Third world nations require immediate access to inexpensive therapeutics to counter the high mortali...
A series of protein farnesyltransferase inhibitor ester prodrugs of FTI-2148 (17) were synthesized i...
Third world nations require immediate access to inexpensive therapeutics to counter the high mortali...
A new class of 2-oxo-tetrahydro-1,8-naphthyridine-based protein farnesyltransferase inhibitors were ...
Substituted tetrahydroquinolines (THQs) have been previously identified as inhibitors of mammalian p...
Substituted tetrahydroquinolines (THQs) have been previously identified as inhibitors of mammalian p...
Substituted tetrahydroquinolines (THQs) have been previously identified as inhibitors of mammalian p...
Malaria continues to represent a very serious health problem in the tropics. The current methods of ...
New chemotherapeutics are urgently needed to combat malaria. We previously reported on a novel serie...
New chemotherapeutics are urgently needed to combat malaria. We previously reported on a novel serie...
New therapeutics to combat malaria are desperately needed. Here we show that the enzyme protein farn...
New chemotherapeutics are urgently needed to combat malaria. We previously reported on a novel serie...
New therapeutics to combat malaria are desperately needed. Here we show that the enzyme protein farn...
A series of ester derivatives of 17 with increased lipophilicity were synthesized and tested against...
A series of protein farnesyltransferase inhibitor ester prodrugs of FTI-2148 (17) were synthesized i...
Third world nations require immediate access to inexpensive therapeutics to counter the high mortali...
A series of protein farnesyltransferase inhibitor ester prodrugs of FTI-2148 (17) were synthesized i...
Third world nations require immediate access to inexpensive therapeutics to counter the high mortali...